An uncontrolled study with thiopropazate in the treatment of persistent dyskinesia

Clinical Trial

J V Ananth et al. Psychopharmacol Bull. 1977 Jul.

. 1977 Jul;13(3):9.

No abstract available

Similar articles

Comparison of thiopropazate and trifluoperazine on oral dyskinesia - a double blind study.
Lal S, Ettigi P. Lal S, et al. Curr Ther Res Clin Exp. 1974 Sep;16(9):990-7. Curr Ther Res Clin Exp. 1974. PMID: 4214673 Clinical Trial. No abstract available.
Thiopropazate hydrochloride in persistent dyskinesia.
Singer K, Cheng MN. Singer K, et al. Br Med J. 1971 Oct 2;4(5778):22-5. doi: 10.1136/bmj.4.5778.22. Br Med J. 1971. PMID: 4938244 Free PMC article. Clinical Trial.
Management of tardive dyskinesia with thiopropazate.
Curran JP. Curran JP. Am J Psychiatry. 1973 Aug;130(8):925-7. doi: 10.1176/ajp.130.8.925. Am J Psychiatry. 1973. PMID: 4146097 No abstract available.
Thiopropazate hydrochloride in persistent dyskinesia.
Singer K, Cheng MN. Singer K, et al. Br Med J. 1971 Dec 4;4(5787):626. doi: 10.1136/bmj.4.5787.626-c. Br Med J. 1971. PMID: 5167074 Free PMC article. No abstract available.
Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
Kazamatsuri H, Chien C, Cole JO. Kazamatsuri H, et al. Arch Gen Psychiatry. 1972 Jul;27(1):100-3. doi: 10.1001/archpsyc.1972.01750250086012. Arch Gen Psychiatry. 1972. PMID: 4555826 Clinical Trial. No abstract available.

Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.
Bergman H, Rathbone J, Agarwal V, Soares-Weiser K. Bergman H, et al. Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD000459. doi: 10.1002/14651858.CD000459.pub3. Cochrane Database Syst Rev. 2018. PMID: 29409162 Free PMC article.